Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial
Rizzo, M., et al., Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study
Conspec Sci
[Published correction appears in JAMA
The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size
US$ 23.55
US$ 29.38
US$ 24.25
US$ 22.05
